{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:58:13Z","timestamp":1791914293151,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.coms.2022.10.006","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T18:45:07Z","timestamp":1680547507000},"page":"203-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vesiculobullous Lesions of the Oral Cavity"],"prefix":"10.1016","volume":"35","author":[{"given":"Saja A.","family":"Alramadhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed N.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coms.2022.10.006_bib1","series-title":"Contemporary oral medicine","article-title":"Oral Vesicular and Bullous Lesions","author":"Challacombe","year":"2018"},{"key":"10.1016\/j.coms.2022.10.006_bib2","first-page":"707","article-title":"Oral Soft Tissue Lesions: A Guide to Differential Diagnosis Part II: Surface Alterations","volume":"4","author":"Nikitakis","year":"2015","journal-title":"Braz J Oral Sci"},{"issue":"11","key":"10.1016\/j.coms.2022.10.006_bib3","first-page":"154","article-title":"Vesiculobullous lesions of the oral cavity","volume":"3","author":"Erugula","year":"2016","journal-title":"IAIM"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/1981-863720180001000063368","article-title":"Vesiculobullous autoimmune diseases with oral mucosa manifestations: retrospective and follow-up study","volume":"66","author":"articleGon\u00e7alo","year":"2018","journal-title":"Rgo, Rev Ga\u00fach Odontol"},{"issue":"4","key":"10.1016\/j.coms.2022.10.006_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clindermatol.2011.01.015","article-title":"Oral involvement in autoimmune bullous diseases","volume":"29","author":"Ramos-e-Silva","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.coms.2022.10.006_bib6","series-title":"Dermatology","article-title":"Pemphigus","author":"Amagai","year":"2017"},{"issue":"4","key":"10.1016\/j.coms.2022.10.006_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2020.02.013","article-title":"Autoimmune bullous skin diseases, pemphigus and pemphigoid","volume":"145","author":"Egami","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.coms.2022.10.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41702-017-0008-1","article-title":"A\u00a0brief review of pemphigus vulgaris","volume":"1","author":"Sanders","year":"2017","journal-title":"Biomed Dermatol"},{"issue":"2","key":"10.1016\/j.coms.2022.10.006_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0923-1811(99)00016-X","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai","year":"1999","journal-title":"J\u00a0Dermatol Sci"},{"issue":"12","key":"10.1016\/j.coms.2022.10.006_bib10","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.4103\/jfmpc.jfmpc_765_19","article-title":"Oral mucosal changes in pemphigus vulgaris and its treatment: A case report","volume":"8","author":"Sen","year":"2019","journal-title":"J\u00a0Fam Med Prim Care"},{"key":"10.1016\/j.coms.2022.10.006_bib11","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Pemphigus Nat Rev Dis Primers"},{"issue":"10201","key":"10.1016\/j.coms.2022.10.006_bib12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","volume":"394","author":"Schmidt","year":"2019","journal-title":"Pemphigus Lancet"},{"issue":"4","key":"10.1016\/j.coms.2022.10.006_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/eye.2014.3","article-title":"Cicatricial changes in ocular pemphigus","volume":"28","author":"Chirinos-Salda\u00f1a","year":"2014","journal-title":"Eye (Lond)."},{"issue":"3","key":"10.1016\/j.coms.2022.10.006_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4103\/jfmpc.jfmpc_114_19","article-title":"Pulse therapy: Opening new vistas in treatment of pemphigus","volume":"8","author":"Mustafi","year":"2019","journal-title":"J\u00a0Fam Med Prim Care"},{"key":"10.1016\/j.coms.2022.10.006_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coms.2022.10.006_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jop.12780","article-title":"The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes","volume":"48","author":"Kamaguchi","year":"2019","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.coms.2022.10.006_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.coms.2022.10.006_bib19","article-title":"Management of mucous membrane pemphigoid: a literature review and update [published online ahead of print, 2021 Oct 27]","author":"Alrashdan","year":"2021","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.coms.2022.10.006_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09273948.2020.1783322","article-title":"Single Center Retrospective Study of Patients with Ocular Mucous Membrane Pemphigoid (MMP)","volume":"30","author":"Morel","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.coms.2022.10.006_bib22","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.coms.2022.10.006_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.coms.2022.10.006_bib24","series-title":"Bullous pemphigoid","author":"Baigrie","year":"2021"},{"key":"10.1016\/j.coms.2022.10.006_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"16","key":"10.1016\/j.coms.2022.10.006_bib26","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A\u00a0common major histocompatibility complex class II allele HLA-DQB1\u2217 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.coms.2022.10.006_bib27","doi-asserted-by":"crossref","first-page":"adv00224","DOI":"10.2340\/00015555-3457","article-title":"A\u00a0Systematic Review of Drug-Induced Pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.coms.2022.10.006_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.coms.2022.10.006_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2018.5049","article-title":"Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid","volume":"155","author":"Kridin","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.coms.2022.10.006_bib30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","article-title":"Epidermolysis bullosa acquisita. Report of three cases and review of all published cases","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.coms.2022.10.006_bib32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0190-9622(84)80459-4","article-title":"Epidermolysis bullosa acquisita--a pemphigoid-like disease","volume":"11","author":"Gammon","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.coms.2022.10.006_bib33","doi-asserted-by":"crossref","first-page":"812029","DOI":"10.1155\/2013\/812029","article-title":"Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita","volume":"2013","author":"Ludwig","year":"2013","journal-title":"ISRN Dermatol"},{"issue":"8","key":"10.1016\/j.coms.2022.10.006_bib34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.autrev.2019.06.007","article-title":"Epidermolysis bullosa acquisita: A comprehensive review","volume":"18","author":"Kridin","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.coms.2022.10.006_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.abd.2021.09.010","article-title":"Epidermolysis bullosa acquisita","volume":"97","author":"Miyamoto","year":"2022","journal-title":"An Bras Dermatol"},{"issue":"12","key":"10.1016\/j.coms.2022.10.006_bib36","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/jid.2011.231","article-title":"Black patients of African descent and HLA-DRB1\u221715:03 frequency overrepresented in epidermolysis bullosa acquisita","volume":"131","author":"Zumelzu","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjd.12011","article-title":"Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study","volume":"168","author":"Marzano","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.coms.2022.10.006_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol\/L salt-split skin. Specificity, sensitivity, and practical considerations","volume":"35","author":"Lazarova","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.coms.2022.10.006_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369922000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369922000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:14:29Z","timestamp":1760904869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369922000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1042369922000814"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2022.10.006","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vesiculobullous Lesions of the Oral Cavity","name":"articletitle","label":"Article Title"},{"value":"Oral and Maxillofacial Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coms.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}